Realize Therapeutics

Realize Therapeutics is a life sciences company based in Chicago, Illinois. With a team of three employees, the company is a privately held entity currently generating $2.5 million in annual revenue. Realize Therapeutics focuses on developing microbiome solutions to address the negative impacts of excessive antibiotic use. Their research centers on restoring core deficiencies in the human gut microbiome, leveraging licensed microbe technology from William Davis, MD. Realize's proprietary L. Reuteri LRDR™ core microbe technology and formulations have diverse applications, including medical nutrition, dietary supplements, and potentially pharmaceuticals. The company differentiates itself through its proprietary microbiome technology and its commitment to developing solutions for gut dysbiosis, a growing concern linked to chronic health problems. Realize Therapeutics commercializes its branded products through a multi-channel strategy, partnering with distributors, strategic alliances, and offering direct-to-consumer sales. For inquiries or further information, interested parties can visit Realize Therapeutics' website at realizetherapeutics.com.